Citius Pharmaceuticals, Inc.

CTXR - CIK 0001506251

Market cap-

Rank-

SEC filings625

CTXR income statement (annual)

The table below shows Citius Pharmaceuticals, Inc.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.

Line item	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Revenue	-	-	-	$90.00K	$90.00K	$90.00K
Cost of revenue	-	-	-	-	-	-
Gross profit	-	-	-	-	-	-
R&D	$9.16M	$11.91M	$14.82M	$17.66M	$12.24M	$8.81M
SG&A	$18.53M

CTXR annual revenue (10-K history)

Citius Pharmaceuticals, Inc. reported annual revenue of $90.00K for fiscal year 2022. That is up 0.0% from $90.00K in fiscal 2021. Figures come from the company's audited annual reports as filed with the SEC.

Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.